Harbin Fuerjia Technology Co., Ltd. Class A

Harbin Fuerjia Technology Co., Ltd. Class A

SSZSE:301371
19.82
CNY
+0.19
(+0.97%)
0.90EPS
23.05P/E
10.82BMarket Cap
Apr 23Next Earn
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.8
2.87
3.05
4.02
3.77
3.95
3.87
3.63
4.55
Basic EPS, GAAP
0.43
1.41
1.25
1.96
1.81
1.53
1.27
0.83
0.9
Free Cash Flow per Basic Share
0.46
1.48
1.28
1.57
1.07
1.44
0.94
0.63
- -
Dividend per Share
- -
0.26
1.16
0.92
- -
- -
0.7
1.15
- -
Book Value per Share
0.44
1.61
1.19
4.13
5.94
10.77
10.89
10.95
10.85
Tangible Book Value per Share
0.44
1.61
1.19
2.86
4.67
9.63
9.75
9.81
9.71
Basic Weighted Avg Shares
468
468
520
411
469
490
521
521
520
Sales/Revenue/Turnover
373
1,342
1,585
1,650
1,769
1,934
2,017
1,893
2,366
Operating Margin (%)
70.12
66.39
55.9
63.66
62.07
47.2
39.03
25.34
22.99
Depreciation Expense
- -
1
2
8
13
40
51
51
- -
Net Income, GAAP
200
661
648
806
847
749
661
433
470
Effective Tax Rate (%)
23.3
25.71
29
25.52
25.36
25.39
27.45
26.85
28.48
Profit Margin (%)
53.44
49.24
40.87
48.85
47.89
38.76
32.78
22.85
19.85
Working Capital
204
691
525
1,141
1,459
3,212
3,267
2,841
3,879
LT Debt
- -
- -
1
- -
- -
7
6
3
8
Total Equity
208
755
557
1,933
2,780
5,601
5,662
5,695
5,642
Return on Invested Capital (%)
- -
117.76
82.09
58.57
34.45
17.39
11.51
7.51
8.31
Return on Capital (%)
- -
137.23
98.57
64.58
35.91
17.86
11.73
7.61
8.42
Return on Common Equity (%)
- -
137.23
98.72
64.72
35.95
17.88
11.74
7.62
8.43

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
9
7
7
LT Borrowings
- -
- -
- -
LT Finance Leases
8
9
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
520
520
520
Market Capitalization
11,661
13,523
10,823

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
3,252
4,025
4,161
Cash, Cash Equivalents & STI
1,819
2,482
3,584
Accounts Receivable, Net
51
41
28
Inventories
178
237
330
Total Current Liabilities
241
231
282
Payables & Accruals
- -
- -
- -
ST Debt
9
7
7
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
78.78%
0.58%
Free Cash Flow
- -
-9.77%
-33.26%
Net Income, GAAP
- -
-5.67%
-34.56%
Sales/Revenue/Turnover
- -
3.76%
-6.14%
Total Cash Common Dividend
- -
- -
65.4%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
409
531
527
551
2,017
2025
301
562
- -
596
1,893
2026
548
608
614
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.29
0.36
0.33
0.28
1.27
2025
0.18
0.27
- -
0.21
0.83
2026
0.33
0.16
0.2
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
-0.07
0.7
2025
0.85
0.32
- -
- -
1.15
2026
- -
- -
- -
- -
- -

Company Description

CEO
Na Sun
Full Time Employees
869
Sector
Consumer non-durables
Industry
Household/Personal care
Address
Harbin China
IPO Date
Aug 1, 2023
Website
voolga.net
Business
Harbin Fuerjia Technology Co., Ltd. is a China-based company primarily engaged in the research, development, production, and commercialization of professional skin care products and medical dressings. The company operates across two core business segments: Medical Device Dressings and Functional Cosmetics. Its comprehensive product portfolio comprises medical-grade skin repair dressings, including medical sodium hyaluronate repair dressings, recombinant collagen wound repair patches, medical skin repair liquids, and silicone scar treatment gels; functional facial masks, including deep hydrating, barrier repair, acne treatment, soothing, and anti-aging sheet masks; and specialized skincare formulations, including restorative essences, intensive serums, moisturizing lotions, facial creams, amino acid cleansers, freeze-dried active powder sets, and sun protection emulsions, marketed primarily under the flagship Fuerjia brand. Harbin Fuerjia Technology distributes its products nationwide across the People's Republic of China, serving medical aesthetic institutions, dermatology departments, retail pharmacy chains, beauty specialty stores, and consumers through major online e-commerce platforms and livestreaming retail channels. Founded in 2017 and headquartered in Harbin, Heilongjiang Province, the company completed its initial public offering on the Shenzhen Stock Exchange ChiNext board. In recent operational developments, the company commissioned its large-scale intelligent manufacturing industrial park in Harbin, expanding automated in-house production capacity for both medical devices and cosmetics formulations. Furthermore, Harbin Fuerjia has strategically broadened its technological pipeline through collaborative research partnerships focusing on recombinant collagen biomaterials and active peptide synthesis, launched next-generation recombinant type III collagen skin-repair product lines, and optimized its omnichannel supply chain and direct-to-consumer distribution infrastructure.